Literature DB >> 9597130

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

S Ghosh1, M J May, E B Kopp.   

Abstract

The transcription factor NF-kappa B, more than a decade after its discovery, remains an exciting and active area of study. The involvement of NF-kappa B in the expression of numerous cytokines and adhesion molecules has supported its role as an evolutionarily conserved coordinating element in the organism's response to situations of infection, stress, and injury. Recently, significant advances have been made in elucidating the details of the pathways through which signals are transmitted to the NF-kappa B:I kappa B complex in the cytosol. The field now awaits the discovery and characterization of the kinase responsible for the inducible phosphorylation of I kappa B proteins. Another exciting development has been the demonstration that in certain situations NF-kappa B acts as an anti-apoptotic protein; therefore, elucidation of the mechanism by which NF-kappa B protects against cell death is an important goal. Finally, the generation of knockouts of members of the NF-kappa B/I kappa B family has allowed the study of the roles of these proteins in normal development and physiology. In this review, we discuss some of these recent findings and their implications for the study of NF-kappa B.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597130     DOI: 10.1146/annurev.immunol.16.1.225

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  1344 in total

Review 1.  Regulation of inducible gene expression by the transcription factor NF-kappaB.

Authors:  S Ghosh
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Regulation of cell cycle transcription factor Swi4 through auto-inhibition of DNA binding.

Authors:  K Baetz; B Andrews
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 3.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 4.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Authors:  G Zhang; S Ghosh
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

5.  NF-kappa B may determine whether epithelial cell--microbial interactions in the intestine are hostile or friendly.

Authors:  Y R Mahida; S Johal
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

6.  Activation of the Drosophila NF-kappaB factor Relish by rapid endoproteolytic cleavage.

Authors:  S Stöven; I Ando; L Kadalayil; Y Engström; D Hultmark
Journal:  EMBO Rep       Date:  2000-10       Impact factor: 8.807

7.  ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway.

Authors:  E Kopp; R Medzhitov; J Carothers; C Xiao; I Douglas; C A Janeway; S Ghosh
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

8.  Transcriptional activation by NF-kappaB requires multiple coactivators.

Authors:  K A Sheppard; D W Rose; Z K Haque; R Kurokawa; E McInerney; S Westin; D Thanos; M G Rosenfeld; C K Glass; T Collins
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

9.  NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.

Authors:  C Y Wang; D C Guttridge; M W Mayo; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

10.  Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.

Authors:  M S Mulligan; A B Lentsch; M Huber-Lang; R F Guo; V Sarma; C D Wright; T R Ulich; P A Ward
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.